1. Home
  2. CUE vs ESGL Comparison

CUE vs ESGL Comparison

Compare CUE & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • ESGL
  • Stock Information
  • Founded
  • CUE 2014
  • ESGL 1999
  • Country
  • CUE United States
  • ESGL Singapore
  • Employees
  • CUE N/A
  • ESGL N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • ESGL
  • Sector
  • CUE Health Care
  • ESGL
  • Exchange
  • CUE Nasdaq
  • ESGL Nasdaq
  • Market Cap
  • CUE 58.9M
  • ESGL 76.4M
  • IPO Year
  • CUE 2018
  • ESGL N/A
  • Fundamental
  • Price
  • CUE $0.77
  • ESGL $2.05
  • Analyst Decision
  • CUE Strong Buy
  • ESGL
  • Analyst Count
  • CUE 3
  • ESGL 0
  • Target Price
  • CUE $3.00
  • ESGL N/A
  • AVG Volume (30 Days)
  • CUE 159.5K
  • ESGL 17.1K
  • Earning Date
  • CUE 05-20-2025
  • ESGL 05-20-2025
  • Dividend Yield
  • CUE N/A
  • ESGL N/A
  • EPS Growth
  • CUE N/A
  • ESGL N/A
  • EPS
  • CUE N/A
  • ESGL N/A
  • Revenue
  • CUE $9,287,000.00
  • ESGL $6,526,924.00
  • Revenue This Year
  • CUE N/A
  • ESGL N/A
  • Revenue Next Year
  • CUE $25.99
  • ESGL N/A
  • P/E Ratio
  • CUE N/A
  • ESGL N/A
  • Revenue Growth
  • CUE 69.16
  • ESGL 3.05
  • 52 Week Low
  • CUE $0.45
  • ESGL $0.55
  • 52 Week High
  • CUE $2.26
  • ESGL $3.00
  • Technical
  • Relative Strength Index (RSI)
  • CUE 44.09
  • ESGL 55.24
  • Support Level
  • CUE $0.71
  • ESGL $1.91
  • Resistance Level
  • CUE $0.78
  • ESGL $2.18
  • Average True Range (ATR)
  • CUE 0.06
  • ESGL 0.13
  • MACD
  • CUE 0.01
  • ESGL 0.00
  • Stochastic Oscillator
  • CUE 38.26
  • ESGL 69.56

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About ESGL ESGL Holdings Limited

ESGL Holdings Ltd Formerly Environmental Solutions Group Holdings Ltd is a waste management, treatment and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical and electroplating companies.

Share on Social Networks: